Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.
- DOI
- 10.1080/09546634.2026.2670906
- Published
- 2026 Dec
- Container
- The Journal of dermatological treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/09546634.2026.2670906,
title = {Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.},
author = {Zhao Y and Zhang F and Yang B and Zhang L and Wu L and Ding Y and Wang J and Li Y and Diao Q and Li J and Sun Q and Zhu X and Man X and Wang L and Feng Y and Cai T and Zeng H and Li L and Lu J and Ren H and Li F and Lu Q and Tao X and Xiao R and Zhang C and Xia X and Cheng H and Ji C and Zhao W and Qiu Y and Chu W and Yan H and Chen B and Zhang J},
year = {2026},
journal = {The Journal of dermatological treatment},
doi = {10.1080/09546634.2026.2670906},
url = {https://doi.org/10.1080/09546634.2026.2670906}
}RIS
TY - JOUR TI - Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials. AU - Zhao Y AU - Zhang F AU - Yang B AU - Zhang L AU - Wu L AU - Ding Y AU - Wang J AU - Li Y AU - Diao Q AU - Li J AU - Sun Q AU - Zhu X AU - Man X AU - Wang L AU - Feng Y AU - Cai T AU - Zeng H AU - Li L AU - Lu J AU - Ren H AU - Li F AU - Lu Q AU - Tao X AU - Xiao R AU - Zhang C AU - Xia X AU - Cheng H AU - Ji C AU - Zhao W AU - Qiu Y AU - Chu W AU - Yan H AU - Chen B AU - Zhang J PY - 2026 JO - The Journal of dermatological treatment DO - 10.1080/09546634.2026.2670906 UR - https://doi.org/10.1080/09546634.2026.2670906 ER -
APA
Y, Z., F, Z., B, Y., L, Z., L, W., Y, D., J, W., Y, L., Q, D., J, L., Q, S., X, Z., X, M., L, W., Y, F., T, C., H, Z., L, L., J, L., H, R., F, L., Q, L., X, T., R, X., C, Z., X, X., H, C., C, J., W, Z., Y, Q., W, C., H, Y., B, C., & J, Z. (2026). Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.. The Journal of dermatological treatment. https://doi.org/10.1080/09546634.2026.2670906
Source records
- pubmed · retrieved 2026-09-27T15:12:11.336Z